1. |
Jemal A, Siegel R, Xu J, et al. Cancer statistics. CA Cancer J Clin, 2010, 60(5): 277-300.
|
2. |
Chute JP, Chen T, Feigal E, et al. Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer. Perceptible progress. J Clin Oncol, 1999, 17(6): 1794-1801.
|
3. |
支修益, 石远凯, 于金明. 中国原发性肺癌诊疗规范(2015年版). 中华肿瘤杂志, 2015, 37(1): 67-68.
|
4. |
Kaneko M, Kusumoto M, Kobayashi T, et al. Computed tomography screening for lung carcinoma in Japan. Cancer, 2000, 89(11 Suppl): 2484-2488.
|
5. |
Verhagen AF, Bulten J, Shirango H, et al. The clinical value of lymphatic micrometastases in patients with non-small cell lung cancer. J Torac Oncol, 2010, 5(8): 1201-1205.
|
6. |
Darling GE, Allen MS, Decker PA, et al. Number of lymph nodes harvested from a mediastinally mphadenectomy: Results of the randomized, prospective ACOSOG Z0030 Trial. Chest, 2010, 139(5): 1124-1129.
|
7. |
孙即昆, 主编. 肺外科学. 北京: 人民卫生出版社, 1987. 24-25.
|
8. |
Takahashi K, Stanford W, VanBeek E, et al. Mediastinal lymphatic drainage from pulmonary lobe based on CT observations of histoplasmosis: implications for minimal N2 disease of non-small-cell lung cancer. Radiat Med, 2007, 25(8): 393-401.
|
9. |
Naruke T, Suemasu K, Ishikawa S. Lymphnode mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg, 1978, 76(6): 832-839.
|
10. |
Goldstraw P, Crowley J, Chansky K, et al. The ISALC Lung Cancer staging project:proposal for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol, 2007, 2(1): 706-714.
|
11. |
Henschke CI, Yankelevitz DF, Libby DM, et al. Survival of patients with stage I lung cancer detected on CT screen. N Engl J Med, 2006, 355(17): 1763-1771.
|
12. |
Kim EA, Johkoh T, Lee KS, et al. Quantification of ground-glass opacity on high-resolution CT of small peripheral adenocarcinoma of the lung: pathologic and prognostic implications. AJR Am J Roentgenol, 2001, 177(6): 1417-1422.
|
13. |
Kodama K, Higashiyama M, Yokouchi H, et al. Prognostic value of groundglass opacity found in small lung adenocarcinoma on high-resolution CT scanning. Lung Cancer, 2001, 33(1): 17-25.
|
14. |
章智荣, 毛有生, 赫捷, 等. 临床I期非小细胞肺癌淋巴结转移规律和清扫方式的探讨. 中华肿瘤杂志, 2014, 36(6): 536-540.
|
15. |
Takizawa T, Terashima M, Koike T, et al. Lymph node metastasis in small peripheral adenocarcinoma of the lung. J Thorac Cardiovasc Surg, 1998, 116(2): 276-280.
|
16. |
Suzuki K, Nagai K, Yoshida J, et al. Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer. J Thorac Cardiovasc Surg, 1999, 117(3): 593-598.
|
17. |
Takamochi K, Nagai K, Suzuki K, et al. Clinical predictors of N2 disease in non-small cell lung cancer. J Chest, 2000, 117(6): 1577-1582.
|
18. |
Misthos P, Sepsas E, Athanassiadi K, et al. Skip metastases:analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer. Eur J Cardiothorac Surg, 2004, 25(4): 502-508.
|
19. |
Prenzel KL, Monig SP, Sinning JM, et al. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancers. J Surg Oncol, 2003, 82(4): 256-260.
|
20. |
蒋浩, 陈军, 张银文. T1肺癌淋巴结转移规律的临床研究. 中国临床医生, 2014, 42(6): 54-55.
|
21. |
谢远才, 李运, 王俊, 等. 直径≤3cm的周围型非小细胞肺癌纵隔淋巴结转移规律的初步研究. 中国微创外科杂志, 2010, 10(7): 577-580.
|